Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.86 B2.36 B1.99 B2.03 B1.86 B 8.24 B Research & development 379 M403 M378 M438 M387 M 1.61 B Operating income 1.27 B760 M1.15 B1.5 B1.34 B 4.76 B Non-Operating Income, Total -154 M-78 M-26 M-173 M-123 M -400 M Interest expense, net of interest capitalized 72 M71 M67 M55 M63 M 256 M Non-Operating Income, excl. Interest Expenses -147 M-107 M-79 M-141 M-113 M -440 M Unusual income/expense -79 M-42 M-14 M-87 M-73 M -216 M Pretax income 1.13 B655 M1.08 B1.37 B1.24 B 4.34 B Equity in earnings ————— — Taxes 175 M100 M168 M190 M206 M 664 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 954 M555 M908 M1.2 B1.03 B 3.69 B Discontinued operations ———0— — Net income 954 M555 M908 M1.2 B1.03 B 3.69 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 954 M555 M908 M1.2 B1.03 B 3.69 B Basic earnings per share (Basic EPS) 1.330.771.281.691.45 5.19 Diluted earnings per share (Diluted EPS) 1.320.771.271.691.45 5.18 Average basic shares outstanding 716.3 M716.5 M710.7 M712.7 M707.9 M — Diluted shares outstanding 720.8 M719.1 M713.7 M716.1 M711.2 M — EBITDA 1.44 B513 M1.24 B1.68 B1.54 B 4.97 B EBIT 849 M-98 M620 M-209 M910 M 1.22 B Cost of revenue 2.23 B2.41 B2.53 B2.87 B2.36 B 10.18 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 591 M611 M622 M1.89 B627 M 3.75 B